150 related articles for article (PubMed ID: 20052806)
1. Arsenic: a beneficial therapeutic poison - a historical overview.
Thomas X; Troncy J
Adler Mus Bull; 2009 Jun; 35(1):3-13. PubMed ID: 20052806
[TBL] [Abstract][Full Text] [Related]
2. The medicinal use of realgar (As₄S₄) and its recent development as an anticancer agent.
Wu J; Shao Y; Liu J; Chen G; Ho PC
J Ethnopharmacol; 2011 Jun; 135(3):595-602. PubMed ID: 21497649
[TBL] [Abstract][Full Text] [Related]
3. Introduction: the history of arsenic trioxide in cancer therapy.
Antman KH
Oncologist; 2001; 6 Suppl 2():1-2. PubMed ID: 11331433
[TBL] [Abstract][Full Text] [Related]
4. A biography of arsenic and medicine in Hong Kong and China.
Au WY
Hong Kong Med J; 2011 Dec; 17(6):507-13. PubMed ID: 22147326
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide in the management of acute promyelocytic leukaemia.
Mathews V; Chandy M; Srivastava A
Natl Med J India; 2001; 14(4):215-22. PubMed ID: 11547528
[TBL] [Abstract][Full Text] [Related]
6. History of the development of arsenic derivatives in cancer therapy.
Waxman S; Anderson KC
Oncologist; 2001; 6 Suppl 2():3-10. PubMed ID: 11331434
[TBL] [Abstract][Full Text] [Related]
7. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent.
Amadori S; Fenaux P; Ludwig H; O'dwyer M; Sanz M
Curr Med Res Opin; 2005 Mar; 21(3):403-11. PubMed ID: 15811209
[TBL] [Abstract][Full Text] [Related]
8. Fowler's Solution and the Evolution of the Use of Arsenic in Modern Medicine.
Ho D; Lowenstein EJ
Skinmed; 2016; 14(4):287-289. PubMed ID: 27784519
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide: new preparation. Acute promyelocytic leukaemia: encouraging results but persistent doubts.
Prescrire Int; 2004 Aug; 13(72):135-7. PubMed ID: 15532137
[TBL] [Abstract][Full Text] [Related]
10. BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity.
Puccetti E; Güller S; Orleth A; Brüggenolte N; Hoelzer D; Ottmann OG; Ruthardt M
Cancer Res; 2000 Jul; 60(13):3409-13. PubMed ID: 10910048
[TBL] [Abstract][Full Text] [Related]
11. Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy.
Berenson JR; Yeh HS
Clin Lymphoma Myeloma; 2006 Nov; 7(3):192-8. PubMed ID: 17229334
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.
Douer D; Tallman MS
J Clin Oncol; 2005 Apr; 23(10):2396-410. PubMed ID: 15800332
[TBL] [Abstract][Full Text] [Related]
13. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide as effective therapy for relapsed acute promyelocytic leukemia.
Mayorga J; Richardson-Hardin C; Dicke KA
Clin J Oncol Nurs; 2002; 6(6):341-6. PubMed ID: 12434466
[TBL] [Abstract][Full Text] [Related]
15. Arsenic in food and water--a brief history.
Sambu S; Wilson R
Toxicol Ind Health; 2008 May; 24(4):217-26. PubMed ID: 19022874
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukemia: a historical perspective.
Goldman JM
Semin Hematol; 2010 Oct; 47(4):302-11. PubMed ID: 20875546
[TBL] [Abstract][Full Text] [Related]
18. [Elementary exploration of the origin and development of marine Chinese materia medica].
Guan HS; Fu XJ; Wu QM; Wang CY; Wang Y; Jiang DZ
Zhonghua Yi Shi Za Zhi; 2009 May; 39(3):168-72. PubMed ID: 19930925
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide: insights into its evolution to an anticancer agent.
Hoonjan M; Jadhav V; Bhatt P
J Biol Inorg Chem; 2018 May; 23(3):313-329. PubMed ID: 29396610
[TBL] [Abstract][Full Text] [Related]
20. [Safety issues of traditional Chinese medical preparations containing arsenic substances: review starting from Niuhuang Jiedu Pian (Wan)].
Zhang L; Gao SH; Zhou CF; Lin RC; Liu CH
Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):2010-3. PubMed ID: 17348199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
